» Articles » PMID: 14607842

Complement Resistance of Borrelia Burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and is Unrelated to Erp Proteins

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Nov 11
PMID 14607842
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

The etiologic agent of Lyme disease, Borrelia burgdorferi, is capable of circumventing the immune defense of a variety of potential vertebrate hosts. Previous work has shown that interaction of host-derived complement regulators, factor H and factor H-like protein 1 (FHL-1), with up to five complement regulator-acquiring surface proteins (CRASPs) expressed by resistant B. burgdorferi sensu lato isolates conferred complement resistance. In addition expression of CRASP-1 is directly correlated with complement resistance of Borrelia species. This work describes the functional characterization of BbCRASP-1 as the dominant factor H and FHL-1-binding protein of B. burgdorferi. The corresponding gene, zs7.a68, is located on the linear plasmid lp54 and is different from factor H-binding Erp proteins that are encoded by genes localized on circular plasmids (cp32). Deletion mutants of BbCRASP-1 were generated, and a high affinity binding site for factor H and FHL-1 was mapped to the C terminus of BbCRASP-1. Similarly, the predominant binding site of factor H and FHL-1 was localized to the short consensus repeat 7. Factor H and FHL-1 maintain their cofactor activity for factor I-mediated C3b inactivation when bound to BbCRASP-1, and factor H is up to 6-fold more efficient in mediating C3b conversion than FHL-1. In conclusion, BbCRASP-1 (i). binds the host complement regulators factor H and FHL-1 with high affinity, (ii). is the key molecule of the complement resistance of spirochetes, and (iii). is distinct from the Erp protein family. Thus, BbCRASP-1 most likely contributes to persistence of B. burgdorferi and to pathogenesis of Lyme disease.

Citing Articles

Complement therapeutic Factor H-IgG proteins as pre-exposure prophylaxes against Lyme borreliae infections.

McKaig C, Malfetano J, Tran Y, Yang X, Pal U, Wycoff K bioRxiv. 2024; .

PMID: 39386713 PMC: 11463399. DOI: 10.1101/2024.09.26.615144.


Hitchhiker's Guide to .

Bourgeois J, Hu L J Bacteriol. 2024; 206(9):e0011624.

PMID: 39140751 PMC: 11411949. DOI: 10.1128/jb.00116-24.


Production, purification, and quality assessment of borrelial proteins CspZ from Borrelia burgdorferi and FhbA from Borrelia hermsii.

Guerin M, Vandevenne M, Brans A, Matagne A, Marquant R, Prost E Appl Microbiol Biotechnol. 2024; 108(1):425.

PMID: 39042328 PMC: 11266248. DOI: 10.1007/s00253-024-13195-2.


Comparative genomics analysis of three conserved plasmid families in the Western Hemisphere soft tick-borne relapsing fever borreliae provides insight into variation in genome structure and antigenic variation systems.

Kneubehl A, Lopez J Microbiol Spectr. 2023; :e0089523.

PMID: 37737593 PMC: 10580987. DOI: 10.1128/spectrum.00895-23.


Sequence Variation of Candida albicans Sap2 Enhances Fungal Pathogenicity via Complement Evasion and Macrophage M2-Like Phenotype Induction.

Lin L, Wang M, Zeng J, Mao Y, Qin R, Deng J Adv Sci (Weinh). 2023; 10(20):e2206713.

PMID: 37211685 PMC: 10369283. DOI: 10.1002/advs.202206713.